CVB homepage TrendingThe key to AI cardiology analytics is human actionU.S. Supreme Court sides with generic drug maker for severe hypertriglyceridemia agent icosapent ethylAI detection of cardiac amyloidosis on ECG granted patentFDA clears first dedicated tricuspid surgical valveRadiologists: Take the deep dive into advanced cardiovascular CT at SCCTACC-AHA release first cardiovascular-kidney-metabolic syndrome guidelinesScience shows the deep relationship between cardiac, kidney and metabolism issues that may impact up to 90% of the U.S. population. BioCardia raises $4.4 million in financing for its heart failure cell therapiesFunds with help bring its cellular therapeutics to market in the next year.New guideline standardizes echo guidance for mitral transcatheter edge-to-edge repairsThe new guideline emphasizes the importance of 3D multiplanar reconstruction for M-TEER to increase precision.Star Trek star's family awarded $13M in heart failure malpractice caseNichelle Nichols, who played Lt. Uhura in Star Trek, died from undiagnosed and untreated heart failure after seeking medical treatment.Longest-distance robotic cardiac telesurgery ever performed over 12,500 milesA left internal mammary artery takedown robot-assisted heart procedure is the latest milestone for an Indian robotics company.First US patient implanted with Biotronik leadless pacemakerThe LivIQ leadless pacemaker offers a single-device solution designed to deliver AV synchrony through far-field sensing. Seven-second X-ray assesses severity of regurgitation congenital heart defect patientsMoving X-ray images can help evaluate pulmonary regurgitation in Tetralogy of Fallot patients.The key to AI cardiology analytics is human actionWhile AI analytics has greatly increased the ease of access to vast amounts of cardiology data, action is still required to make it useful. U.S. Supreme Court sides with generic drug maker for severe hypertriglyceridemia agent icosapent ethylThe decision clears the way for Hikma Pharmaceuticals' sale of icosapent ethyl in the U.S. market. Load MoreInnovation at workCardiovascular Business Fewer biopsies, happier patients: Why molecular blood testing is a game-changer for managing heart transplant recipientsFollow-up care after a successful heart transplant can be challenging—both for providers and their patients. Consider, for example, the fact that so many patients who develop complications never actually present with symptoms. In cooperation with CareDxAround the webRadiology Business Large language model helps radiology department boost patients’ report comprehensionRadiology Business Solis Mammography expands in Florida with 2 new centersHealth Exec Where children thrive, according to measures of general health and overall wellbeing
